SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-18-006148
Filing Date
2018-01-08
Accepted
2018-01-08 17:20:03
Documents
2
Group Members
KEVIN FERROVATERA HEALTHCARE PARTNERS LLCVHPM HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d522297dsc13da.htm SC 13D/A 84407
2 EX-99.6 d522297dex996.htm EX-99.6 6412
  Complete submission text file 0001193125-18-006148.txt   92605
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86624 | Film No.: 18517233
SIC: 2834 Pharmaceutical Preparations

Mailing Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212-590-2950
VATERA HOLDINGS LLC (Filed by) CIK: 0001548880 (see all company filings)

IRS No.: 208894647 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A